Filing Details

Accession Number:
0001217234-22-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-06 18:07:36
Reporting Period:
2022-01-05
Accepted Time:
2022-01-06 18:07:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1217234 Caredx Inc. CDNA Services-Medical Laboratories (8071) 943316839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1613855 Peter Maag C/O Caredx, Inc.
1 Tower Place, 9Th Floor
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-05 925 $6.31 342,681 No 4 M Direct
Common Stock Acquisiton 2022-01-05 3,340 $24.35 346,021 No 4 M Direct
Common Stock Acquisiton 2022-01-05 5,735 $27.17 351,756 No 4 M Direct
Common Stock Disposition 2022-01-05 8,146 $44.29 343,610 No 4 S Direct
Common Stock Disposition 2022-01-05 1,854 $45.13 341,756 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2022-01-05 925 $0.00 925 $6.31
Common Stock Employee Stock Option (right to buy) Disposition 2022-01-05 3,340 $0.00 3,340 $24.35
Common Stock Employee Stock Option (right to buy) Disposition 2022-01-05 5,735 $0.00 5,735 $27.17
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,165 2028-01-19 No 4 M Direct
41,667 2030-02-03 No 4 M Direct
61,164 2029-02-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect As UTMA custodian for minor child
Common Stock 1,000 Indirect As UTMA custodian for minor child
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.85 to $44.80, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45 to $45.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  4. Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  5. 1/4th of the shares subject to the option shall vested January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
  6. 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.
  7. 1/4th of the shares subject to the option vested on January 25, 2020 and 1/48th of the shares subject to the option vest monthly thereafter.